semaglutide for non obese Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review | Pharmaceutical Research GLP-1 Weight Loss for Normal

Ducharme is simply fantastic

Interested in Starting GLP-1 Treatment

Groups at higher risk of deficiency include older adults (due to reduced stomach acid production), people following vegan or strict vegetarian diets (as B12 is naturally found almost exclusively in animal products), individuals with pernicious anaemia or other malabsorption conditions, those taking certain medications such as metformin or proton pump inhibitors long-term, and people with significant nitrous oxide exposure (including recreational use), which can inactivate B12 in the body

doi: 10.1038/ni.1831 70 AarrebergLDEsser-NobisKDriscollCShuvarikovARobyJAGale JrM

While this slower digestion is beneficial for controlling appetite, it can sometimes slow the digestive process too much, leading to gastroparesis

Increases in Prepregnancy Obesity: United States, 20162019